Democratic Republic of the Congo
Democratic Republic of the Congo
Explore linked clinical trials.20 results · Page 1 of 1
Cities
Swipe the table sideways for more columns.
| Cities | City | Country | Linked trials |
|---|---|---|---|
| Boende | Boende | Democratic Republic of the Congo | 1 |
| Boende | Boende | Democratic Republic of the Congo | 1 |
| Bukavu | Bukavu | Democratic Republic of the Congo | 3 |
| Bukavu | Bukavu | Democratic Republic of the Congo | 3 |
| Bunia | Bunia | Democratic Republic of the Congo | 2 |
| Bwamanda | Bwamanda | Democratic Republic of the Congo | 1 |
| Goma | Goma | Democratic Republic of the Congo | 2 |
| Goma | Goma | Democratic Republic of the Congo | 1 |
| Kamituga | Kamituga | Democratic Republic of the Congo | 1 |
| Kenge | Kenge | Democratic Republic of the Congo | 1 |
| Kinshasa | Kinshasa | Democratic Republic of the Congo | 1 |
| Kinshasa | Kinshasa | Democratic Republic of the Congo | 1 |
| Kinshasa | Kinshasa | Democratic Republic of the Congo | 5 |
| Kinshasa | Kinshasa | Democratic Republic of the Congo | 18 |
| Kinshasa | Kinshasa | Democratic Republic of the Congo | 1 |
| Kinshasa | Kinshasa | Democratic Republic of the Congo | 1 |
| Lubumbashi | Lubumbashi | Democratic Republic of the Congo | 4 |
| Mbandaka | Mbandaka | Democratic Republic of the Congo | 3 |
| Rethy | Rethy | Democratic Republic of the Congo | 1 |
| Rethy | Rethy | Democratic Republic of the Congo | 1 |
45 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Vaccines Against Bundibugyo Virus Disease in Contacts of Cases in the Democratic Republic of the Congo | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Phase 2 / Phase 3 | 2026-10-05 | NCT07842107 | |
| RVF and Other Emerging Infectious Diseases in East and Central Africa | Bunyaviridae infectious disease, Communicable Diseases, Emerging, Digestive System Diseases, Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Rift valley fever, arbovirus infection, hepatitis, hepatitis, non-human animal, hepatitis, viral, animal, infectious disease, liver disorder, non-human animal disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Not stated | 2026-10-05 | NCT05139524 | |
| Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo. | Bacterial Infections and Mycoses, Enterobacteriaceae Infections, Infections, Yersinia infectious disease, bacterial infectious disease, gram-negative bacterial infections, plague, vector-borne disease | Not yet recruiting | Not stated | 2026-09-29 | NCT07174648 | |
| AI Blind-Sweep Ultrasound for Antenatal Screening by Non-Specialist Health Workers in Rural DR Congo | Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Urogenital Diseases, placenta disorder, placenta praevia, pregnancy disorder | Recruiting | Not stated | 2026-09-15 | NCT07677670 | |
| Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC) | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Recruiting | Not stated | 2026-08-31 | NCT07093489 | |
| Low-cost Negative Pressure Wound Therapy vs Standard Dressings for Gustilo IIIb Tibial Fractures (Bukavu Pilot RCT) | Leg Injuries, bone fracture, injury, tibia fracture | Not yet recruiting | Not applicable | 2026-08-27 | NCT07790991 | |
| Stop Transmission of Gambiense Human African Trypanosomiasis | Euglenozoa Infections, Infections, parasitic infectious disease, protozoa infectious disease, trypanosomiasis | Recruiting | Phase 3 | 2026-08-27 | NCT07789743 | |
| Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes | Aedes-Borne Diseases, Infections, Mosquito-Borne Diseases, vector-borne disease | Recruiting | Not applicable | 2026-08-19 | NCT06981442 | |
| Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 4 | 2026-08-12 | NCT05745987 | |
| A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa | DNA Virus Infections, Infections, Orthopoxvirus Infection, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease | Recruiting | Phase 2 | 2026-08-11 | NCT07379580 | |
| Surveillance of AMR in DRC | Bacterial Infections and Mycoses, Infections, Inflammation, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, bacterial infectious disease, bacterial infectious disease with sepsis, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2026-07-23 | NCT06821282 | |
| Realizing Effectiveness Across Continents With Hydroxyurea (REACH) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-06-30 | NCT01966731 | |
| Caffeine for Hypoxic Ischemic Encephalopathy | Hypoxia, Hypoxia, Brain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, brain disorder, brain hypoxia - ischemia, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, vascular disorder | Recruiting | Phase 3 | 2026-06-24 | NCT06855108 | |
| Validation of SDS-EDTA-Treated Chromatography Paper Strips for Mpox Sampling and Transport in DRC | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Recruiting | Not stated | 2026-06-11 | NCT07634081 | |
| Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX): Clinical Study to Monitor the Immunological Response Following Mpox Vaccination in the City of Kinshasa, Democratic Republic of the Congo | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 4 | 2026-06-11 | NCT07499739 | |
| An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 2 | 2026-05-19 | NCT06839989 | |
| Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics | Death, Female Urogenital Diseases and Pregnancy Complications, Fetal Death, Infections, Mosquito-Borne Diseases, Obstetric Labor Complications, Obstetric Labor, Premature, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Plasmodium falciparum malaria, Premature Birth, Urogenital Diseases, malaria, parasitic infectious disease, pregnancy disorder, pregnancy disorder with abortive outcome, protozoa infectious disease, vector-borne disease | Active, not recruiting | Phase 4 | 2026-05-07 | NCT05757167 | |
| Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease | Active, not recruiting | Phase 3 | 2026-04-29 | NCT06844487 | |
| Realizing Effectiveness Across Continents With Hydroxyurea | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Active, not recruiting | Phase 2 | 2026-04-21 | NCT06171217 | |
| Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Buruli ulcer disease, Disease Attributes, Euglenozoa Infections, Flea Infestations, Hemic and Lymphatic Diseases, Infections, Mosquito-Borne Diseases, Mycobacterium Infections, Nontuberculous, Neglected Diseases, Neglected Tropical Diseases, Nematoda infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Secernentea Infections, Skin Ulcer, Skin and Connective Tissue Diseases, Spirurida Infections, Treponema infectious disease, bacterial infectious disease, cutaneous leishmaniasis, dermatomycosis, elephantiasis, filarial elephantiasis, filariasis, fungal infectious disease, gram-negative bacterial infections, gram-positive bacterial infections, helminthiasis, leishmaniasis, leprosy, lymphatic system disorder, lymphedema, mite infestation, mycetoma, mycobacterial infectious disease, nocardiosis, onchocerciasis, parasitic ectoparasitic infectious disease, parasitic infectious disease, parasitic skin disorder, podoconiosis, protozoa infectious disease, scabies, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, spirochaetales infections, tungiasis, vector-borne disease, yaws | Not yet recruiting | Not applicable | 2026-04-02 | NCT07506967 | |
| Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma | Eye Diseases, Hereditary, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, eye disorder, neoplasm, neuroepithelial neoplasm, ocular cancer, primitive neuroectodermal tumor, retinal cancer, retinal disorder, retinoblastoma | Recruiting | Not stated | 2026-03-02 | NCT04425434 | |
| Recommendations for the Treatment of Children With Burkitt's Lymphoma | B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease | Recruiting | Not stated | 2026-03-02 | NCT04425421 | |
| Therapeutic Recommendations for Nephroblastoma | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Wilms tumor, benign urinary system neoplasm, hereditary disease, hereditary neoplastic syndrome, kidney cancer, kidney disorder, mixed neoplasm, neoplasm, urinary system disorder | Recruiting | Not stated | 2026-03-02 | NCT04423484 | |
| Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella Disease | Infections, Mosquito-Borne Diseases, invasive non-typhoidal salmonellosis, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2026-02-18 | NCT07416461 | |
| Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease | Active, not recruiting | Phase 3 | 2026-01-30 | NCT06844500 |